19 May 2013
Keywords: pacific, phase, brain, tumor, trials, duke, pharmaceuticals
Article | 22 September 1998
Pacific Pharmaceuticals has announced that a Phase I trial of itsbrain tumor chemosensitizer, O6 benzyl guanine, will be carried out ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 September 1998
17 May 2013
© 2013 thepharmaletter.com